US Patent Issued to Agency for Science, Technology and Research on Sept. 9 for "Methods for generating mimetic innate immune cells from pluripotent stem cells" (Singaporean Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,400, issued on Sept. 9, was assigned to Agency for Science, Technology and Research (Singapore).

"Methods for generating mimetic innate immune cells from pluripotent stem cells" was invented by Jieming Zeng (Singapore) and Shu Wang (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "Human pluripotent stem cells (hPSCs), especially induced pluripotent stem cells (iPSCs) provide a promising starting material to produce mimetic innate immune cells such as natural killer (NK) cells and GammaDelta T-cells for cancer immunotherapy. To facilitate consistent mass production, an overall manufacturing scheme to make mimetic innate immune cells from hPS...